JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.16% |
| 2 | Healthcare | 10.79% |
| 3 | Financials | 9.36% |
| 4 | Consumer Discretionary | 8.67% |
| 5 | Industrials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VERV
1401
DELISTED
Verve Therapeutics
VERV
| $27.5M | ﹤0.01% |
1,908,364
+119,902
| +7% | +$2.35M |
|
1402
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.2B
| $27.5M | ﹤0.01% |
773,723
-165,310
| -18% | -$5.81M |
|
1403
CALL
Emerson Electric
EMR
$91.4B
| $27.5M | ﹤0.01% |
315,200
+244,000
| +343% | +$21.3M |
|
1404
PUT
Prudential Financial
PRU
$42.3B
| $27.5M | ﹤0.01% |
331,900
+7,100
| +2% | +$678K |
|
|
DOCU
1405
CALL
DocuSign
DOCU
$11.1B
| $27.5M | ﹤0.01% |
471,000
+62,100
| +15% | +$3.7M |
|
1406
Cabot Corp
CBT
$4.45B
| $27.4M | ﹤0.01% |
357,945
+24,321
| +7% | +$1.82M |
|
|
NS
1407
DELISTED
NuStar Energy L.P.
NS
| $27.4M | ﹤0.01% |
1,752,770
+217,417
| +14% | +$3.54M |
|
1408
Liberty Media Series C
FWONK
$26B
| $27.4M | ﹤0.01% |
378,296
+77,534
| +26% | +$5.24M |
|
|
CUK
1409
DELISTED
Carnival PLC
CUK
| $27.4M | ﹤0.01% |
2,989,709
-165,126
| -5% | -$1.54M |
|
1410
NiSource
NI
$20.1B
| $27.3M | ﹤0.01% |
974,743
+14,187
| +1% | +$388K |
|
1411
Bunge Global
BG
$21.5B
| $27.3M | ﹤0.01% |
285,285
-262,042
| -48% | -$25.5M |
|
1412
Enova International
ENVA
$6.48B
| $27.2M | ﹤0.01% |
611,920
+176,313
| +40% | +$8M |
|
1413
KraneShares CSI China Internet ETF
KWEB
$5.31B
| $27.2M | ﹤0.01% |
870,770
-6,115,439
| -88% | -$196M |
|
1414
Ameris Bancorp
ABCB
$6B
| $27.2M | ﹤0.01% |
742,231
+283,307
| +62% | +$12.7M |
|
1415
CALL
IBM
IBM
$223B
| $27.1M | ﹤0.01% |
206,400
-205,900
| -50% | -$27.5M |
|
1416
PUT
Pfizer
PFE
$153B
| $27.1M | ﹤0.01% |
663,100
-815,600
| -55% | -$35.2M |
|
|
VRE
1417
DELISTED
Veris Residential
VRE
| $27M | ﹤0.01% |
1,846,721
-395,656
| -18% | -$6.31M |
|
1418
Home BancShares
HOMB
$6.23B
| $27M | ﹤0.01% |
1,244,481
+162,245
| +15% | +$3.75M |
|
1419
CALL
Logitech
LOGI
$14.8B
| $27M | ﹤0.01% |
464,700
+436,800
| +1,566% | +$24.8M |
|
|
MODV
1420
DELISTED
ModivCare
MODV
| $27M | ﹤0.01% |
320,572
+5,207
| +2% | +$501K |
|
1421
CALL
State Street SPDR Portfolio Europe ETF
SPEU
$743M
| $26.9M | ﹤0.01% |
+600,000
| New | +$22.4M |
|
1422
iShares US Infrastructure ETF
IFRA
$4.62B
| $26.9M | ﹤0.01% |
719,981
+73,944
| +11% | +$2.79M |
|
|
RXDX
1423
CALL
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $26.8M | ﹤0.01% |
250,000
+46,600
| +23% | +$5.36M |
|
1424
Legend Biotech
LEGN
$3.93B
| $26.8M | ﹤0.01% |
556,016
+83,615
| +18% | +$4.09M |
|
|
CMA
1425
DELISTED
Comerica
CMA
| $26.8M | ﹤0.01% |
617,021
+103,375
| +20% | +$6.62M |
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 752 new, 3,315 increased, 2,057 reduced and 651 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 752 new positions and closed 651 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.